FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...
Indiatimes1h
US FDA lifts clinical hold on Novavax's combo Covid-flu shot
They pared their gains and were last up 2%. The Maryland-based biotech announced the clinical hold last month after a ...
Yahoo Finance3h
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
and stand-alone influenza vaccine candidates. The FDA has cleared the Company to begin enrolling the planned Phase 3 trial ...
Morningstar3h
Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold
Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold. The Gaithersburg, Md., vaccine developer said Monday that the U.S. Food ...
BioPharma Dive17h
FDA lifts pause on Novavax flu vaccine trials
The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...
Seeking Alpha3h
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
and stand-alone influenza vaccine candidates. The vaccine candidates were placed on clinical hold last month after report of a serious adverse event in a single CIC Phase 2 trial participant who ...
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
Delta Optimist19h
Fraser Health offers flu and COVID shots at the same time
And, says the health authority, you can get both shots at once and save a trip. "People will have the opportunity to receive ...
Novavax, Inc.: U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...
Monthly Prescribing Reference1h
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...